Wegovy 9Mg Tablets 30S

• Semaglutide 9 mg oral tablets • Once-daily GLP-1 receptor agonist in tablet form • For chronic weight management in adults with obesity or overweight with a weight-related condition • Also reduces risk of major cardiovascular events in adults with established heart disease and obesity/overweight • Prescription-only medicine • Pack contains 30 tablets (1 bottle, 1-month supply)

Wegovy 9 mg Tablets contain semaglutide, a GLP-1 receptor agonist available as an oral tablet formulated with SNAC to aid absorption through the stomach lining. Taken once daily, it mimics the natural GLP-1 hormone to reduce appetite, slow gastric emptying and support significant, sustained weight loss when combined with a reduced-calorie diet and increased physical activity. Wegovy tablets are indicated for adults with obesity, or overweight with at least one weight-related condition, and to reduce the risk of major adverse cardiovascular events such as heart attack and stroke in adults with established cardiovascular disease and obesity or overweight. The 9 mg dose is typically reached after titrating up from the 1.5 mg and 4 mg tablets. Benefits • Supports meaningful, sustained weight loss alongside diet and exercise • Reduces risk of major cardiovascular events in at-risk adults • Convenient oral tablet, no injections required • Once-daily dosing fits easily into a daily routine • Helps regulate appetite and reduce calorie intake • Backed by extensive clinical research on semaglutide How to use • Take 1 tablet once daily, first thing in the morning, on an empty stomach • Swallow whole with up to half a glass (120 mL) of plain water only • Wait at least 30 minutes before eating, drinking anything else, or taking other oral medications • Do not crush, chew or split the tablet • Dose is typically increased gradually under medical supervision (from 1.5 mg to 4 mg to 9 mg, and higher if needed) • Do not use with other semaglutide-containing products or other GLP-1 receptor agonist medicines • Consult your doctor before use if pregnant, breastfeeding, or with a personal/family history of thyroid cancer